WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

2.05.26

Wilson Sonsini Advises SpyGlass Pharma on $150 Million IPO
On February 5, 2026, SpyGlass Pharma, Inc., a late-stage biopharmaceutical company, announced the pricing of its initial public offering of 9,375,000 shares of its common stock at a public offering price of $16.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by SpyGlass Pharma, are expected to be approximately $150 million. Wilson Sonsini Goodrich & Rosati advised SpyGlass Pharma on the transaction.

SpyGlass Pharma has granted the underwriters a 30-day option to purchase up to an additional 1,406,250 shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by SpyGlass Pharma. SpyGlass Pharma’s common stock is expected to begin trading on the Nasdaq Global Select Market on February 6, 2026, under the ticker symbol “SGP.” The offering is expected to close on February 9, 2026, subject to the satisfaction of customary closing conditions.

The Wilson Sonsini team that advised SpyGlass Pharma includes:
Client Highlights

12.08.25

Wilson Sonsini Advises Foresight Diagnostics on Acquisition by Natera
On December 5, 2025, Natera, Inc., a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular residual disease (MRD) detection, announced that Natera has completed its acquisition of Foresight in an all-stock transaction consisting of a $275 million upfront payment with an additional $175 million in earnouts tied to the achievement of revenue- and reimbursement-based milestones. Wilson Sonsini Goodrich & Rosati advised Foresight on the transaction.

The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
Client Highlights

12.05.25

Wilson Sonsini Advises Secure on Acquisition by HSA Bank
On December 4, 2025, HSA Bank, a division of Webster Bank N.A., and Webster Financial Corporation, the holding company for Webster Bank, announced that it has acquired Secure Inc. (d/b/a SecureSave), a leading provider of employer-sponsored emergency savings accounts (ESAs). Wilson Sonsini Goodrich & Rosati advised Secure on the transaction.

With this acquisition, HSA Bank will become one of the largest providers of emergency savings accounts in the country and SecureSave will continue to operate with its current platform and serve its clients who will benefit from HSA Bank’s suite of products.
Client Highlights

9.22.25

Wilson Sonsini Advises Netskope on IPO
On September 17, 2025, Netskope, a leader in modern security and networking for the cloud and AI era, announced the pricing of its initial public offering of 47,800,000 shares of its Class A common stock at a public offering price of $19.00 per share. The shares began trading on the Nasdaq Global Select Market on September 18, 2025, under the ticker symbol “NTSK.” The offering closed on September 19, 2025. Additionally, on September 22, 2025, Netskope announced the full exercise of its over-allotment option of 7,170,000 shares of Class A common stock. Wilson Sonsini Goodrich & Rosati advised Netskope on the transaction.
Client Highlights

9.19.25

Wilson Sonsini Advises Anysphere on Acquisition of Koala
Anysphere, the company behind the artificial intelligence coding application Cursor, acquired Koala, an AI-powered customer relationship management start-up. The acquisition brings Koala’s top engineers to Cursor to help build out a dedicated enterprise-readiness team. Wilson Sonsini Goodrich & Rosati advised Anysphere on the transaction.
Client Highlights

7.09.25

Wilson Sonsini Advises Jony Ive and LoveFrom on $6.5 Billion Acquisition of io Products by OpenAI
On July 9, 2025, OpenAI closed its acquisition of io Products, a hardware start-up company co-founded by Jony Ive, for approximately $6.5 billion in stock. Jony Ive and his design firm, LoveFrom, will remain independent and assume deep design and creative responsibilities across OpenAI. Wilson Sonsini advised Jony Ive and LoveFrom on the transaction.
Client Highlights

6.13.25

Wilson Sonsini Advises Scale AI on $14.35 Billion Investment from Meta
On June 12, 2025, Scale AI, Inc., the humanity-first AI company, announced a $14.35 billion investment from Meta Platforms, Inc. that values Scale at over $29 billion. The agreement will also substantially expand Scale and Meta’s commercial relationship to accelerate deployment of Scale’s data solutions. Wilson Sonsini Goodrich & Rosati is advising Scale on the transaction.

In addition, Scale’s founder, Alexandr Wang, is joining Meta to work on Meta’s AI efforts. He will continue to serve as a director on Scale’s board of directors and support Scale’s ongoing work to unlock the power of AI and keep human values at the forefront.

Scale will distribute proceeds from Meta’s investment to Scale shareholders and vested equity holders, providing them with substantial liquidity as well as the opportunity to continue participating in Scale’s success as ongoing equity holders of the company. Following its investment, Meta will hold a minority of Scale’s outstanding equity.

The Wilson Sonsini team advising Scale on the transaction was led by partners Rezwan Pavri, Marty Korman, Rich Mullen, John Brust, and Lester Ang. The team also included: 
Client Highlights

5.21.25

Wilson Sonsini Advises Halo Labs on Acquisition by Waters
On May 21, 2025, Waters Corporation announced that it acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. Wilson Sonsini Goodrich & Rosati advised Halo Labs on the transaction.
Client Highlights

4.09.25

Wilson Sonsini Advises Marvell on Infineon's $2.5 Billion Acquisition of Automotive Ethernet Business
On April 8, 2025, Marvell Technology, a leader in data infrastructure semiconductor solutions, announced that it has entered into a definitive agreement under which Infineon Technologies will acquire Marvell's Automotive Ethernet business in an all-cash transaction valued at $2.5 billion. Wilson Sonsini Goodrich & Rosati advised Marvell on the transaction.
Client Highlights

4.04.25

Wilson Sonsini Advises Skilljar on Acquisition by Gainsight
On April 2, 2025, Gainsight, a world-leading Customer Success platform that helps business drive growth by unifying the post-sales customer journey, acquired Skilljar, a leading Learning Management Software (LMS) provider for external training. Wilson Sonsini Goodrich & Rosati advised Skilljar on the transaction.  

Building on Skilljar’s AI progress, Gainsight is reinforcing its commitment to embarking on an Agentic journey to deliver personalized learning at scale, further underscoring its commitment to driving revenue growth and exceptional customer outcomes. The acquisition also bolsters Gainsight’s established and thriving customer education community by uniting it with Skilljar, creating a leading collective of industry experts to drive this transformative vision.

The Wilson Sonsini team that advised Skilljar on the transaction includes:
Client Highlights

10.22.24

Wilson Sonsini Advises Stripe on Acquisition of Bridge
On October 21, 2024, financial infrastructure platform Stripe confirmed that it is acquiring stablecoin infrastructure provider Bridge. Wilson Sonsini Goodrich & Rosati advised Stripe on the transaction.

“Stablecoins are room-temperature superconductors for financial services. Thanks to stablecoins, businesses around the world will benefit from significant speed, coverage, and cost improvements in the coming years. Stripe is going to build the world’s best stablecoin infrastructure, and, to that end, we are delighted to welcome Bridge to Stripe,” wrote Stripe CEO Patrick Collison on X.

The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close in the coming months.

The Wilson Sonsini team that advised Stripe on the transaction includes:
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.